Sarah Gheuens, Chief Medical Officer at AGIOS PHARMACEUTICALS, INC. (AGIO), sold 5,818 shares at $33.54 ($195K) on 2025-06-24, disclosed to the SEC on 2025-06-26.
Scheduled sale ($195k) by Chief Medical Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $33.54 | 2,909 | $98K | 50.0% |
| 2 | $33.54 | 2,909 | $98K | 50.0% |
| Total | $33.54 avg | 5,818 | $195K | 100% |
| Filing → |
| AGIO | SELL | 2026-04-06 | $102K | — | Filing → |
| AGIO | SELL | 2026-03-03 | $83K | — | Filing → |
| AGIO | SELL | 2026-01-02 | $79K | — | Filing → |